A Look into Pegfilgrastim Biosimilars Industry Player Activities and Strategies

Because the pegfilgrastim biosimilars market is highly concentrated with only a few large players, gaining an in-depth understanding of the top competitors and their key strategies is crucial. A new report by The Business Research Company provides detailed information on the pegfilgrastim biosimilars competitive landscape. Read on to learn key insights from the report.

Topics: Pharmaceuticals Industry Insights

COVID-19 Accelerates Use of AI in the Pharmaceutical Industry

The COVID-19 pandemic has sped up the adoption of artificial intelligence (AI) in the pharma market in domains such as healthcare.

Topics: Software & Enterprise Computing Pharmaceuticals Industry Insights

The Rapidly Evolving mRNA Vaccines and Therapeutics Market

One of the new classes of vaccines, mRNA-based vaccines facilitate cells in the body to make specific proteins for triggering an immune response, further producing antibodies against a specific disease.

Topics: Pharmaceuticals Industry Insights

Top 6 Things to Know About the $30 Billion Sleep Aids Market

As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stress in 2020 related to the presidential election, Covid-19 pandemic and recession are all contributing to more sleepless nights.

Topics: House & Home Pharmaceuticals Medical Devices Industry Insights

Winners and Losers in the Consumer Goods Industry During Q4-2020

International trade data can represent an accurate barometer of the state of the health of the global economy, even more so in the current extraordinary circumstances, that require up-to-date monitoring for companies involved in international business.

Topics: Food & Beverage House & Home Retail Apparel Pharmaceuticals Healthcare Industry Insights

U.S. Weight Loss Industry Struggles in 2020, but Commercial Chains Survive Pandemic

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the coronavirus hit last March, shutting the doors of many weight loss centers, doctors’ offices, clinics, and other businesses for 8–10 weeks. As a result, the market’s value is estimated to have fallen by 21%.
Topics: Food & Beverage Pharmaceuticals Healthcare

COVID-19 Vaccines: The Blockbuster Drugs of 2021

For the pharmaceutical industry and the broader scientific community, creating and producing effective COVID-19 vaccines has been a challenge and opportunity of a lifetime — a chance to help save humanity from an urgent global crisis.

Topics: Pharmaceuticals Industry Insights

$2 Billion U.S. Autism Treatment Market Is Poised for Growth Next Year

There are 3.5 million children and adults with autism in America. The North American market for autism disorder treatment is expected to grow over the next five years, due to a variety of factors:
Topics: Pharmaceuticals Healthcare Industry Insights

The Coronavirus’ Effect on the Health Care Industry

The Coronavirus pandemic created new risks for patients and care givers alike. Significant new safety practices and costs will be standard for years to come—perhaps forever, as we seek to eliminate the spread of the Coronavirus as well as any future viral threats.

Topics: Pharmaceuticals Healthcare Industry Insights

The Growing Market for Chronic Lower Back Pain (CLBP)

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Topics: Pharmaceuticals Healthcare Industry Insights